This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Paul Rohricht
Chief Business Officer – Pharma at Nuritas Corporation


Paul Rohricht, MS MBA, is Chief Business Officer-Pharma, for Dublin-based AI drug discovery company Nuritas, and is based in Philadelphia. Prior to Nuritas, Mr. Rohricht has held senior business development positions with early-stage med tech firms including ChemImage and Symphogen, and is the co-founder of Revivicor, which was sold to United Therapeutics. He has also previously held the position of Entrepreneur-in-Residence at Wake Forest School of Medicine. He is also a US and EU patent holder, with several others pending. He is a graduate of St. Olaf College and the Wharton School of Business.

Agenda Sessions

  • Discussion Panel: Challenges in the application of AI and Machine Learning in Drug Discovery - Different challenges for different entities